GlaxoSmithKline received a boost yesterday after the British drug maker won a contract to supply its cervical cancer vaccine for the government's immunisation programme for schoolgirls. The world's second-biggest drugs manufacturer did not disclose the value of the three-year contract for its Cervarix vaccine but there has been industry speculation that it could be worth about £100m.
Link to Article
Additional Story
GlaxoSmithKline wins NHS contract to supply cervical cancer vaccine - The Times 19th June 2008
Glaxo wins UK deal for cervical cancer vaccine - The Guardian 19th June 2008
Monday, June 23, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment